COSMO PHARMACEUTICALS NVCOSMO PHARMACEUTICALS NVCOSMO PHARMACEUTICALS NV

COSMO PHARMACEUTICALS NV

No trades
See on Supercharts

COPN fundamentals

COSMO PHARMACEUTICALS NV financial statements, including revenue, expenses, and profit

The total revenue of COPN for the last semiannual is 131.06 M EUR, and it's 3.66% lower compared to the previous semiannual. The net income of H2 24 is 57.35 M EUR.

Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth